1
|
Yamamoto S: Stomach cancer incidence in
the world. Jpn J Clin Oncol. 31:4712001.PubMed/NCBI
|
2
|
Ahn YO, Park BJ, Yoo KY, et al: Incidence
estimation of stomach cancer among Koreans. J Korean Med Sci.
6:7–14. 1991. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Correa P: Human gastric carcinogenesis: A
multistep and multifactorial process - First American Cancer
Society award lecture on cancer epidemiology and prevention. Cancer
Res. 52:6735–6740. 1992.PubMed/NCBI
|
5
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Matter K and Balda MS: Signalling to and
from tight junctions. Nat Rev Mol Cell Biol. 4:225–236. 2003.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Mitic LL, Van Itallie CM and Anderson JM:
Molecular physiology and pathophysiology of tight junctions I.
Tight junction structure and function: lessons from mutant animals
and proteins. Am J Physiol Gastrointest Liver Physiol.
279:G250–G254. 2000.PubMed/NCBI
|
9
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Mitic LL and Anderson JM: Molecular
architecture of tight junctions. Annu Rev Physiol. 60:121–142.
1998. View Article : Google Scholar : PubMed/NCBI
|
11
|
Martin TA and Jiang WG: Tight junctions
and their role in cancer metastasis. Histol Histopathol.
16:1183–1195. 2001.PubMed/NCBI
|
12
|
Langbein L, Pape UF, Grund C, et al: Tight
junction-related structures in the absence of a lumen: occludin,
claudins and tight junction plaque proteins in densely packed cell
formations of stratified epithelia and squamous cell carcinomas.
Eur J Cell Biol. 82:385–400. 2003. View Article : Google Scholar : PubMed/NCBI
|
13
|
Itoh M and Bissell MJ: The organization of
tight junctions in epithelia: implications for mammary gland
biology and breast tumorigenesis. J Mammary Gland Biol Neoplasia.
8:449–462. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Turksen K and Troy TC: Barriers built on
claudins. J Cell Sci. 117:(12 Pt). 2435–2447. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Soini Y, Tommola S, Helin H and
Martikainen P: Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of
claudin expression associates with the diffuse subtype. Virchows
Arch. 448:52–58. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Jung H, Jun KH, Jung JH, Chin HM and Park
WB: The expression of claudin-1, claudin-2, claudin-3 and claudin-4
in gastric cancer tissue. J Surg Res. 167:e185–e191. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Wu YL, Zhang S, Wang GR and Chen YP:
Expression transformation of claudin-1 in the process of gastric
adenocarcinoma invasion. World J Gastroenterol. 14:4943–4948. 2008.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Ohtani S, Terashima M, Satoh J, et al:
Expression of tight-junction-associated proteins in human gastric
cancer: downregulation of claudin-4 correlates with tumor
aggressiveness and survival. Gastric Cancer. 12:43–51. 2009.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Resnick MB, Gavilanez M, Newton E, et al:
Claudin expression in gastric adenocarcinomas: a tissue microarray
study with prognostic correlation. Hum Pathol. 36:886–892. 2005.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Michl P, Barth C, Buchholz M, et al:
Claudin-4 expression decreases invasiveness and metastatic
potential of pancreatic cancer. Cancer Res. 63:6265–6271.
2003.PubMed/NCBI
|
21
|
Agarwal R, D'Souza T and Morin PJ:
Claudin-3 and claudin-4 expression in ovarian epithelial cells
enhances invasion and is associated with increased matrix
metalloproteinase-2 activity. Cancer Res. 65:7378–7385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Japanese Gastric Cancer Association, .
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Sano T and Aiko T: New Japanese
classifications and treatment guidelines for gastric cancer:
Revision concepts and major revised points. Gastric Cancer.
14:97–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ikenouchi J, Matsuda M, Furuse M and
Tsukita S: Regulation of tight junctions during the
epithelium-mesenchyme transition: Direct repression of the gene
expression of claudins/occludin by Snail. J Cell Sci.
116:1959–1967. 2003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Itoh M, Furuse M, Morita K, Kubota K,
Saitou M and Tsukita S: Direct binding of three tight
junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH
termini of claudins. J Cell Biol. 147:1351–1363. 1999. View Article : Google Scholar : PubMed/NCBI
|
26
|
Gottardi CJ, Arpin M, Fanning AS and
Louvard D: The junction-associated protein, zonula occludens-1,
localizes to the nucleus before the maturation and during the
remodeling of cell-cell contacts. Proc Natl Acad Sci USA.
93:10779–10784. 1996. View Article : Google Scholar : PubMed/NCBI
|
27
|
Jechlinger M, Grunert S, Tamir IH, et al:
Expression profiling of epithelial plasticity in tumor progression.
Oncogene. 22:7155–7169. 2003. View Article : Google Scholar : PubMed/NCBI
|
28
|
Tsukita S and Furuse M: Pores in the wall:
claudins constitute tight junction strands containing aqueous
pores. J Cell Biol. 149:13–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hoevel T, Macek R, Swisshelm K and Kubbies
M: Reexpression of the TJ protein CLDN1 induces apoptosis in breast
tumor spheroids. Int J Cancer. 108:374–383. 2004. View Article : Google Scholar : PubMed/NCBI
|
30
|
Matsuda Y, Semba S, Ueda J, et al: Gastric
and intestinal claudin expression at the invasive front of gastric
carcinoma. Cancer Sci. 98:1014–1019. 2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Resnick MB, Konkin T, Routhier J, Sabo E
and Pricolo VE: Claudin-1 is a strong prognostic indicator in stage
II colonic cancer: A tissue microarray study. Mod Pathol.
18:511–518. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Satake S, Semba S, Matsuda Y, et al: Cdx2
transcription factor regulates claudin-3 and claudin-4 expression
during intestinal differentiation of gastric carcinoma. Pathol Int.
58:156–163. 2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Xin S, Huixin C, Benchang S, et al:
Expression of Cdx2 and claudin-2 in the multistage tissue of
gastric carcinogenesis. Oncology. 73:357–365. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Krämer F, White K, Kubbies M, Swisshelm K
and Weber BH: Genomic organization of claudin-1 and its assessment
in hereditary and sporadic breast cancer. Hum Genet. 107:249–256.
2000. View Article : Google Scholar : PubMed/NCBI
|
35
|
Tokés AM, Kulka J, Paku S, et al:
Claudin-1, -3 and -4 proteins and mRNA expression in benign and
malignant breast lesions: A research study. Breast Cancer Res.
7:R296–R305. 2005. View
Article : Google Scholar : PubMed/NCBI
|
36
|
Kominsky SL, Argani P, Korz D, et al: Loss
of the tight junction protein claudin-7 correlates with
histological grade in both ductal carcinoma in situ and invasive
ductal carcinoma of the breast. Oncogene. 22:2021–2033. 2003.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Liebner S, Fischmann A, Rascher G, et al:
Claudin-1 and claudin-5 expression and tight junction morphology
are altered in blood vessels of human glioblastoma multiforme. Acta
Neuropathol. 100:323–331. 2000. View Article : Google Scholar : PubMed/NCBI
|
38
|
Martin TA and Jiang WG: Loss of tight
junction barrier function and its role in cancer metastasis.
Biochim Biophys Acta. 1788:872–891. 2009. View Article : Google Scholar : PubMed/NCBI
|
39
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
40
|
Ming SC: Gastric carcinoma. A
pathobiological classification. Cancer. 39:2475–2485. 1977.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Sugano H, Nakamura K and Kato Y:
Pathological studies of human gastric cancer. Acta Pathol Jpn.
32:(Suppl 2). 329–347. 1982.PubMed/NCBI
|
42
|
Adachi Y, Yasuda K, Inomata M, Sato K,
Shiraishi N and Kitano S: Pathology and prognosis of gastric
carcinoma: Well versus poorly differentiated type. Cancer.
89:1418–1424. 2000. View Article : Google Scholar : PubMed/NCBI
|
43
|
Park JM, Jang YJ, Kim JH, et al: Gastric
cancer histology: Clinicopathologic characteristics and prognostic
value. J Surg Oncol. 98:520–525. 2008. View Article : Google Scholar : PubMed/NCBI
|
44
|
Zhu JL, Gao P, Wang ZN, et al:
Clinicopathological significance of claudin-4 in gastric carcinoma.
World J Surg Oncol. 11:1502013. View Article : Google Scholar : PubMed/NCBI
|
45
|
Kuo WL, Lee LY, Wu CM, et al: Differential
expression of claudin-4 between intestinal and diffuse-type gastric
cancer. Oncol Rep. 16:729–734. 2006.PubMed/NCBI
|
46
|
Lee SK, Moon J, Park SW, Song SY, Chung JB
and Kang JK: Loss of the tight junction protein claudin 4
correlates with histological growth-pattern and differentiation in
advanced gastric adenocarcinoma. Oncol Rep. 13:193–199.
2005.PubMed/NCBI
|
47
|
Kominsky SL, Vali M, Korz D, et al:
Clostridium perfringens enterotoxin elicits rapid and specific
cytolysis of breast carcinoma cells mediated through tight junction
proteins claudin 3 and 4. Am J Pathol. 164:1627–1633. 2004.
View Article : Google Scholar : PubMed/NCBI
|